These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 32029246

  • 1. Effect of Residual Interatrial Shunt on Migraine Burden After Transcatheter Closure of Patent Foramen Ovale.
    Ben-Assa E, Rengifo-Moreno P, Al-Bawardy R, Kolte D, Cigarroa R, Cruz-Gonzalez I, Sakhuja R, Elmariah S, Pomerantsev E, Vaina LM, Ning M, Buonanno FS, Hung JW, Inglessis I, Palacios IF.
    JACC Cardiovasc Interv; 2020 Feb 10; 13(3):293-302. PubMed ID: 32029246
    [Abstract] [Full Text] [Related]

  • 2. Frequency of migraine headache relief following patent foramen ovale "closure" despite residual right-to-left shunt.
    Jesurum JT, Fuller CJ, Kim CJ, Krabill KA, Spencer MP, Olsen JV, Likosky WH, Reisman M.
    Am J Cardiol; 2008 Oct 01; 102(7):916-20. PubMed ID: 18805122
    [Abstract] [Full Text] [Related]

  • 3. Impact of Percutaneous Closure of Interatrial Shunts on Migraine Attacks: Single-Operator Series and Review of the Literature.
    Manolis AS.
    Rev Recent Clin Trials; 2017 Oct 01; 12(2):129-138. PubMed ID: 28356032
    [Abstract] [Full Text] [Related]

  • 4. Improvement of migraine headaches after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism.
    Wahl A, Praz F, Tai T, Findling O, Walpoth N, Nedeltchev K, Schwerzmann M, Windecker S, Mattle HP, Meier B.
    Heart; 2010 Jun 01; 96(12):967-73. PubMed ID: 20538672
    [Abstract] [Full Text] [Related]

  • 5. Is it too early to recommend patent foramen ovale closure for all patients who suffer from migraine? A single-centre study.
    Chessa M, Colombo C, Butera G, Negura D, Piazza L, Varotto L, Bussadori C, Fesslova V, Meola G, Carminati M.
    J Cardiovasc Med (Hagerstown); 2009 May 01; 10(5):401-5. PubMed ID: 19449455
    [Abstract] [Full Text] [Related]

  • 6. Transcatheter patent foramen ovale closure is effective in reducing migraine independently from specific interatrial septum anatomy and closure devices design.
    Rigatelli G, Cardaioli P, Dell'Avvocata F, Giordan M, Braggion G, Chinaglia M, Roncon L.
    Cardiovasc Revasc Med; 2010 May 01; 11(1):29-33. PubMed ID: 20129358
    [Abstract] [Full Text] [Related]

  • 7. Long-term impact of transcatheter closure interatrial shunts on disabling migraine.
    Rigatelli G, Pasquetto G, Zuin M.
    Acta Cardiol; 2024 Jul 01; 79(5):575-581. PubMed ID: 38818761
    [Abstract] [Full Text] [Related]

  • 8. Primary transcatheter patent foramen ovale closure is effective in improving migraine in patients with high-risk anatomic and functional characteristics for paradoxical embolism.
    Rigatelli G, Dell'Avvocata F, Ronco F, Cardaioli P, Giordan M, Braggion G, Aggio S, Chinaglia M, Rigatelli G, Chen JP.
    JACC Cardiovasc Interv; 2010 Mar 01; 3(3):282-7. PubMed ID: 20298985
    [Abstract] [Full Text] [Related]

  • 9. Percutaneous Closure of Patent Foramen Ovale in Patients With Migraine: The PREMIUM Trial.
    Tobis JM, Charles A, Silberstein SD, Sorensen S, Maini B, Horwitz PA, Gurley JC.
    J Am Coll Cardiol; 2017 Dec 05; 70(22):2766-2774. PubMed ID: 29191325
    [Abstract] [Full Text] [Related]

  • 10. Usefulness of transcatheter patent foramen ovale closure in migraineurs with moderate to large right-to-left shunt and instrumental evidence of cerebrovascular damage.
    Papa M, Gaspardone A, Fragasso G, Ajello S, Gioffrè G, Iamele M, Iani C, Margonato A.
    Am J Cardiol; 2009 Aug 01; 104(3):434-9. PubMed ID: 19616680
    [Abstract] [Full Text] [Related]

  • 11. Impact of transcatheter closure of patent foramen ovale in the evolution of migraine and role of residual shunt.
    Biasco L, Infantino V, Orzan F, Vicentini S, Rovera C, Longo G, Chinaglia A, Belli R, Allais G, Gaita F.
    J Cardiol; 2014 Nov 01; 64(5):390-4. PubMed ID: 24713153
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Long-term experience and outcomes with transcatheter closure of patent foramen ovale.
    Inglessis I, Elmariah S, Rengifo-Moreno PA, Margey R, O'Callaghan C, Cruz-Gonzalez I, Baron S, Mehrotra P, Tan TC, Hung J, Demirjian ZN, Buonanno FS, Ning M, Silverman SB, Cubeddu RJ, Pomerantsev E, Schainfeld RM, Dec GW, Palacios IF.
    JACC Cardiovasc Interv; 2013 Nov 01; 6(11):1176-83. PubMed ID: 24262618
    [Abstract] [Full Text] [Related]

  • 14. Residual shunt after percutaneous closure of patent foramen ovale with AMPLATZER occluder devices - influence of anatomic features: a transcranial Doppler and intracardiac echocardiography study.
    Marchese N, Pacilli MA, Inchingolo V, Fanelli R, Loperfido F, Vigna C.
    EuroIntervention; 2013 Jul 01; 9(3):382-8. PubMed ID: 23872652
    [Abstract] [Full Text] [Related]

  • 15. Comparison of residual shunt rate and complications across 6 different closure devices for patent foramen ovale.
    Gevorgyan Fleming R, Kumar P, West B, Noureddin N, Rusheen J, Aboulhosn J, Tobis JM.
    Catheter Cardiovasc Interv; 2020 Feb 15; 95(3):365-372. PubMed ID: 31654558
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Incidence and Outcomes of Positive Bubble Contrast Study Results After Transcatheter Closure of a Patent Foramen Ovale.
    Shah AH, Osten M, Benson L, Alnasser S, Bach Y, Vishwanath R, Van De Bruaene A, Shulman H, Navaranjan J, Khan R, Horlick E.
    JACC Cardiovasc Interv; 2018 Jun 11; 11(11):1095-1104. PubMed ID: 29880106
    [Abstract] [Full Text] [Related]

  • 19. Migraine and percutaneous patent foramen ovale closure: a systematic review and meta-analysis.
    Shi YJ, Lv J, Han XT, Luo GG.
    BMC Cardiovasc Disord; 2017 Jul 26; 17(1):203. PubMed ID: 28747203
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.